These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6151998)

  • 1. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prizidilol, a new antihypertensive drug with combined arteriolar vasodilator and beta-adrenoceptor blocking actions, with hydralazine and propranolol in conscious dogs with chronic atrioventricular block.
    Boucher M; Dubray C; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1983; 5(5):712-6. PubMed ID: 6195455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
    Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
    J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
    Steiner JA; Clancy A; Manghani KK; James IM
    Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
    Pitcher DW; Curry PV; Trounce JR
    Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of blood pressure effects of nipradilol and prizidilol in normotensive and spontaneously hypertensive rats.
    Watanabe TX; Sokabe H; Kawashima K
    Jpn J Pharmacol; 1985 Jul; 38(3):273-9. PubMed ID: 3903298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of the stereoisomers of prizidilol: their use in analysis of reflex tachycardia and blood pressure control in normotensive cats, rats, and dogs.
    Owen DA; Eden RJ; Lamb MS; Taylor EM
    J Cardiovasc Pharmacol; 1986; 8(4):743-8. PubMed ID: 2427813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
    Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on agents with vasodilator and beta-blocking activities. II.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of nipradilol (K-351) on isolated rabbit hearts and guinea pig ventricular muscles.
    Kodama I; Anno T; Toyama J; Yamada K
    J Cardiovasc Pharmacol; 1985; 7(6):1013-9. PubMed ID: 2418282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties.
    Fujii M; Shirasawa Y; Kondo S; Sawanobori K; Nakamura M
    Jpn Heart J; 1986 Mar; 27(2):233-50. PubMed ID: 2873263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
    Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology and pharmacokinetics of prizidilol in hypertensive patients.
    Chaignon M; Decourt S; Guelpa G; Rocher I; Flouvat B; Guédon J
    J Cardiovasc Pharmacol; 1983; 5(6):1068-73. PubMed ID: 6196556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.
    Edmondstone WM; Waller JF; Manghani KK; Hill PL; Bell AJ; Denison DM
    Br J Clin Pharmacol; 1983 Dec; 16(6):591-8. PubMed ID: 6140939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.
    Boehringer K; Weidmann P; Link L; Bianchetti MG; Schiffl H; Reubi FC
    Br J Clin Pharmacol; 1983 Feb; 15(2):181-8. PubMed ID: 6133543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
    Nichols AJ; Gellai M; Ruffolo RR
    Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on agents with vasodilator and beta-blocking activities. IV.
    Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic receptor effects and antihypertensive actions of beta-adrenoceptor-blocking agents with ancillary properties.
    Imai S; Nakahara H; Nakazawa M; Takeda K
    Drugs; 1988; 36 Suppl 6():10-9. PubMed ID: 2908298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.